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Abstract Purpose To evaluate safety and image
quality of cardiovascular magnetic resonance (CMR)
at 3.0 T in patients with coronary stents after
myocardial infarction (MI), in comparison to the
clinical standard at 1.5 T. Methods Twenty-ﬁve
patients (21 men; 55 ± 9 years) with ﬁrst MI treated
with primary stenting, underwent 18 scans at 3.0 T
and 18 scans at 1.5 T. Twenty-four scans were
performed 4 ± 2 days and 12 scans 125 ± 23 days
after MI. Cine (steady-state free precession) and late
gadolinium-enhanced (LGE, segmented inversion-
recovery gradient echo) images were acquired.
Patient safety and image artifacts were evaluated,
and in 16 patients stent position was assessed during
repeat catheterization. Additionally, image quality
was scored from 1 (poor quality) to 4 (excellent
quality). Results There were no clinical events within
30 days of CMR at 3.0 T or 1.5 T, and no stent
migration occurred. At 3.0 T, image quality of cine
studies was clinically useful in all, but not sufﬁcient
for quantitative analysis in 44% of the scans, due to
stent (6/18 scans), ﬂow (7/18 scans) and/or dark band
artifacts (8/18 scans). Image quality of LGE images
at 3.0 T was not sufﬁcient for quantitative analysis in
53%, and not clinically useful in 12%. At 1.5 T, all
cine and LGE images were quantitatively analyzable.
Conclusion 3.0 T is safe in the acute and chronic
phase after MI treated with primary stenting.
Although cine imaging at 3.0 T is suitable for clinical
use, quantitative analysis and LGE imaging is less
reliable than at 1.5 T. Further optimization of pulse
sequences at 3.0 T is essential.
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The combination of functional cardiovascular mag-
netic resonance (CMR) and late gadolinium
enhancement (LGE) is evolving as an important
diagnostic [1, 2] and prognostic [3–5] modality in
patients with ischemic heart disease. Because the
availability of high ﬁeld MR systems is increasing,
the need arises to evaluate the performance and
clinical value of these systems in cardiovascular
disease. Earlier reports already suggested that 3.0 T
MR systems offer higher temporal and spatial
resolution, due to an increased signal-to-noise ratio,
which would be especially advantageous in CMR
scanning [6–8]. However, these studies were all
assessed in healthy volunteers and in patients with
non-ischemic heart disease or suspected coronary
artery disease, and without the presence of coronary
stents [6–10]. There is limited to no data about safety
and image quality at 3.0 T CMR scanning in the
acute or chronic phase after myocardial infarction
(MI), in patients treated with percutaneous coronary
intervention and primary stenting. In these patients
B0 inhomogeneities (induced by the heart-lung inter-
face or from coronary stents), ﬂow artifacts,
inhomogeneity of normal myocardial suppression in
LGE (induced by B1 inhomogeneity) and poor
cardiac triggering may interfere with the gain offered
by the higher magnetic ﬁeld.
The aim of this study was to test whether CMR
scanning at 3.0 T is safe and feasible in patients with
coronary stents in the acute and chronic phase after
MI, and to prospectively compare image quality at
3.0 T with the current clinical standard at 1.5 T.
Furthermore, the presence and signiﬁcance of differ-
ent image artifacts are considered.
Methods
Patient population
Patients were eligible for the study if they had been
admittedwithaﬁrstST-elevationacuteMI,accordingto
standard electrocardiographic and enzymatic criteria
[11], and had undergone successful primary PCI with
stent implantation. Exclusion criteria were electrocar-
diographic evidence of reinfarction, haemodynamic or
other clinical instability or (relative) contraindications
for CMR such as claustrophobia, pacemakers, intrace-
rebral aneurysm clips or very irregular heart rhythm.
Patients were treated with aspirin, heparin, abciximab,
clopidogrel, statins, beta-blockade and ACE-inhibitors,
according to ACC/AHA practice guidelines [12]. The
studywasapprovedbythelocalethicscommitteeandall
patients gave written informed consent.
CMR parameters
Eighteen CMR scans were performed with a 3.0 T
MR system (Intera, Philips, Best, The Netherlands),
with a gradient performance of 30 mT/m and slew
rate of 150 T/m/s, using a six element cardiac phased
array surface coil. Another 18 CMR scans were
acquired with a 1.5 T MR system (Magnetom Sonata,
Siemens, Erlangen, Germany), with a gradient per-
formance of 40 mT/m and slew rate of 200 T/m/s,
using an eight element cardiac phased array surface
coil.
Cine imaging was performed at both ﬁeld
strengths using a SSFP pulse sequence, without
parallel imaging. Long axis views, as well as short
axis views covering the entire left ventricle were
acquired during repeated breath-holds in expiration.
At 3.0 T, cine SSFP sequence parameters were a
temporal resolution between 25 ms and 50 ms,
excitation angle of 45 , receiver bandwidth 868 Hz/
pixel, TR/TE of 3.8/1.9 ms, matrix 192 · 155 and
voxel size of 1.5 · 1.8 · 6.0 mm
3. At 1.5 T, the
temporal resolution was between 35 ms and 50 ms
with an excitation angle of 60 , receiver bandwidth
930 Hz/pixel, TR/TE of 3.2/1.6 ms, matrix
256 · 156 and voxel size of 1.4 · 1.9 · 6.0 mm
3.
LGE images were acquired in mid-diastole using a
2D segmented inversion-recovery gradient-echo pulse
sequence, 10–15 min after intravenous injection of
0.2 mmol/kg of a gadolinium chelate (Dotarem,
Guerbet, Roissy, France). The LGE images were
obtained in exactly the same orientation as the cine
images. Sequence parameters at 3.0 T were an exci-
tation angle of 25 , receiver bandwidth 434 Hz/pixel,
TR/TE of 3.5/1.3 ms, matrix 192 · 119, voxel size of
1.7 · 2.1 · 6.0 mm
3, triggering every other heart
beat, and an inversion time between 250 ms and
350 ms to null remote myocardium. At 1.5 T,
sequence parameters were an excitation angle of
25 , receiver bandwidth 130 Hz/pixel, TR/TE of
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1239.6/4.4 ms, matrix 256 · 166, voxel size of
1.4 · 1.7 · 6.0 mm
3, triggering every other heart
beat, and an inversion time between 220 ms and
300 ms to null remote myocardium.
Safety and quality analysis
To evaluate patient safety, a physician was present at
the CMR scanner throughout the scan. Heart rhythm
was monitored continuously. The patient was asked
to report any discomfort and symptoms during the
scan procedure. Additionally, a repeat catheterization
was performed in 16 patients who underwent CMR
examination in the acute phase after MI (9 at 3.0 T, 7
at 1.5 T). Stent position and patency after CMR
scanning were visually assessed on the repeat cath-
eterization and compared to the primary PCI.
Occurrence of repeat intervention or hospitalization
within 30 days of the CMR examination was
recorded.
Different types of artifacts were reviewed and
marked as being clinically relevant if the artifact
interfered with visualisation of the myocardium.
Flow related artifacts in SSFP imaging [13], and
artifacts due to static ﬁeld inhomogeneities such as
the heart-lung interface were scored on cine images.
Separately, we looked at artifacts caused by the
coronary stent on the cine images, and measured the
maximum artifact diameter, perpendicular to the
length of the stent, using an appropriate cardiac
view. In addition, the potential effect of B1 inhomo-
geneity on the homogeneous suppression of viable
myocardium was visually assessed on LGE images.
Furthermore, image quality of the cine and LGE
images were scored on a separate workstation
(Centricity Radiology v6.1, GE Medical Systems,
Zeist, the Netherlands) by four independent observ-
ers, who were blinded for MR system and clinical
history. To distinguish between image quality that is
satisfactory for clinical use or high quality images for
research purposes, images were scored on a scale
from 1 to 4: 1 not clinically useful; 2 clinically useful,
but of insufﬁcient quality for quantitative analysis; 3
clinically useful and of sufﬁcient quality for quanti-
tative analysis; 4 excellent quality. The following
deﬁnitions were used for evaluation of the cine
images: 1 poor quality, extensive artifacts, com-
pletely obscuring endocardial borders; 2 moderate
quality, assessment of global function is possible,
partly using assumptions, but regional wall thicken-
ing is not possible in all segments, due to interfering
artifacts; 3 good quality, assessment of global and
regional function is possible, despite some small
artifacts; 4 excellent quality, functional analysis is
possible and there is no interference of artifacts. And
for the evaluation of LGE images: 1 poor quality,
extensive artifacts, infarcted myocardium is not
visible; 2 moderate quality, infarcted myocardium is
visible, but delineation is not possible in all segments;
3 good quality, infarcted myocardium is easy to
distinguish from viable myocardium, despite some
small artifacts; 4 excellent quality, no artifacts. Two
scores were given for each scan: 1 for the set of cine
images and 1 for the set of LGE images. After
completing the independent image quality assess-
ment, all 4 observers exchanged their scores for each
case and agreed on a consensus score.
Statistical analysis
Continuous variables with normal distribution are
expressed as mean ± SD, or as median (25th–75th
percentile). Comparison of the baseline characteris-
tics and stent artifact diameter was done by using an
unpaired Student’s t-test. The consensus score of
image quality of both ﬁeld strengths was assessed for
statistical difference by a Mann-Whitney U test. All
statistical tests were two-sided with a signiﬁcance
level of P\0.05. SPSS 12.0.1 for Windows (SPSS
Inc., Chicago, USA) was used for analysis.
Results
Twenty-ﬁve consecutive patients with 36 CMR
studies were included in the study. One patient was
studied on both MR systems in the acute phase, 9
patients (5 on 3.0 T, 4 on 1.5 T) were studied both in
the acute phase and in the chronic phase, and 1
patient (3.0 T) was studied twice in the chronic phase
after MI. The baseline characteristics of all 25
patients are listed in Table 1. On each system, 12
CMR scans were performed in the acute phase after
MI, at 4 ± 2 days after primary PCI, and 6 CMR
studies in the chronic phase, at 125 ± 23 days after
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123primary PCI. One patient refused contrast injection
during scanning in the chronic phase.
ECG electrodes were positioned and displaced
until an optimal ECG signal was acquired. Although
it took more time to obtain a stable ECG waveform
with a clearly delineated R wave at 3.0 T than at
1.5 T (10–15 min vs.\2 min respectively), it did not
affect image quality, since scans were repeated when
trigger problems occurred.
Stent safety and artifacts at 3.0 T
No patient reported any discomfort or symptoms
during the CMR scan procedure. In addition, there
were no clinical events during, or shortly after
scanning at 3.0 T, and none of the patients underwent
a repeat intervention or hospitalization for any reason
within 30 days.
The mean number of stents implanted per patient
per scan at 3.0 T was 1.3 ± 0.7, with a mean stent
length of 19 ± 5 mm and diameter of 3.2 ± 0.4 mm.
Further speciﬁcations of the implanted coronary
stents are listed in Table 2. Repeat catheterization
was performed 2 (1–4) days after scanning in 9 of the
12 patients who underwent 3.0 T CMR scanning in
the acute phase after MI. Angiographic evaluation
revealed no differences in stent position and patency
compared to the initial result after primary PCI.
During cine imaging, the coronary stent was
visible in 14 of the 18 scans (78%), with a
susceptibility related signal loss of 12.8 ± 4.3 mm
in diameter. Due to severe interference of the
coronary stent in 6 scans (33%), analysis of sur-
rounding myocardium was impossible (Fig. 1A).
Through-plane ﬂow artifacts were present in 14 scans
(from the aorta in 9 scans, from the pulmonary trunk
in 7 scans, from the left ventricle in 3 scans), and
hindered visualization of the myocardium in 7 scans
(39%). In-plane ﬂow artifacts were present in 4 scans,
but were not clinically relevant. In the majority of the
scans (94%) dark band artifacts appeared at the
Table 1 Patient characteristics
Number of patients 25
Age (years) 55 ± 9
Men 21 (84)
BMI (kg/m
2) 25.5 ± 1.9
Risk factors
Diabetes mellitus 0 (0)
Hyperlipidaemia 3 (12)
Hypertension 6 (24)
Smoking 16 (64)
Family history of CAD 8 (32)
Maximum peak CK-MB (U/L) 308 (197–464)
Infarct-related artery
LAD 18 (72)
RCx 3 (12)
RCA 4 (16)
Values are presented as number (ratio in %), mean ± standard
deviation or median (25th–75th percentile)
Table 2 Type and number of coronary stents used per CMR
examination
Field strength
and timing
Number of
patients
Number and
type of coronary
stents present during CMR
a
3.0 T acute phase 9 1· Multi-Link Vision
12 · Multi-Link Vision
21 · Driver
3.0 T chronic phase 3 1· Multi-Link Vision
21 · Driver/2x TAXUS
Liberte ´
b
11 · Driver
1.5 T acute phase 4 1· Prokinetic
12 · Prokinetic
21 · Lekton Motion
11 · Lekton Motion/2·
Multi-Link Vision
11 · Multi-Link Vision
11 · AVE
11 · Multi-Link Zeta
11 · CYPHER
b
1.5 T chronic phase 2 1· Lekton Motion
12 · Lekton Motion
11 · AVE
11 · Multi-Link Zeta
11 · CYPHER
b
a Stent material and manufacturer—Multi-Link Vision: cobalt
chromium alloy, Abbott Vascular; Driver, cobalt chromium
alloy, Medtronic; TAXUS Liberte ´, 316L stainless steel, Boston
Scientiﬁc; Prokinetic, cobalt chromium alloy, Biotronik;
Lekton Motion: 316L stainless steel, Biotronik; Multi-Link
Zeta, 316L stainless steel, Abbott Vascular; AVE: 316L
stainless steel, Medtronic; CYPHER: 316L stainless steel,
Cordis
b Drug-eluting stent
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123transition between myocardium and lung, with a
predilection for the anterolateral wall, which resulted
in severe image distortion in 8 scans (44%). Overall,
artifacts were responsible for clinically relevant
image deformation in 12 scans (67%), of which half
was caused by the coronary stent (in 6 scans).
No effect could be observed of B1 inhomogeneity
on the suppression of viable myocardium on LGE
images at 3.0 T.
Stent safety and artifacts at 1.5 T
Also during scanning at 1.5 T, no patient reported
any discomfort or symptoms, and there were no
clinical events during, or shortly after scanning. None
of the patients underwent a repeat intervention or
hospitalization for any reason within 30 days after
CMR scanning.
The mean number of implanted stents per patient
per scan at 1.5 T was 1.2 ± 0.5 (see also Table 2).
The mean stent length was 19 ± 5 mm with a mean
diameter of 3.2 ± 0.4 mm, which was comparable
with the stent length and diameter scanned at 3.0 T
(p = ns). In 7 of the 12 patients who underwent CMR
scanning at 1.5 T in the acute phase, repeat catheter-
ization at 2 (2–4) days after scanning revealed no
differences in stent position and patency compared to
post-PCI.
During cine imaging, the coronary stent was
visible in 6 of the 18 scans (33%), with a suscepti-
bility related signal loss of 5.5 ± 0.3 mm in diameter,
which was signiﬁcantly smaller than at 3.0 T
(P\0.01). Furthermore, visible stents did not cause
clinically important image deformation (Fig. 1B).
Besides the small signal void from coronary stents,
no other artifacts were observed at 1.5 T.
Also at 1.5 T there was no effect of B1 inhomo-
geneity on the suppression of viable myocardium on
LGE images.
Evaluation of image quality
With scanning at 3.0 T, localized shimming was
compulsory in every scan to obtain better image
quality (Fig. 2). At 1.5 T, there was no need for
adjustments in sequence parameters or the use of
local shimming to optimize image quality. At 3.0 T,
in 44% of the cases, image quality was not sufﬁcient
for quantitative analysis and assessment of regional
function of the left ventricle (Table 3). For clinical
purposes and global assessment of left ventricular
function, image quality at 3.0 T and 1.5 T were
comparable. Image quality of LGE images was not
sufﬁcient for quantitative analysis in 53% of the cases
at 3.0 T, and 12% of the images were not useful for
clinical purposes. Both image quality of cine and
LGE imaging at 3.0 T were signiﬁcantly lower
compared to 1.5 T (P\0.001).
Discussion
In this paper we report on our initial experience with
CMR scanning at 3.0 T in a clinical situation. We
found that it is safe and feasible to perform CMR
scanning at 3.0 T in the acute and chronic phase after
MI in patients treated with primary stenting. Image
quality of cine imaging at 3.0 T is of sufﬁcient
quality for global assessment of left ventricular
Fig. 1 Short axis cine
SSFP images in different
patients, demonstrating a
signal void from a coronary
stent with myocardial
interference at 3.0 T
(A, white arrow head), and
a smaller signal void
without interference at
1.5 T (B, white arrow head)
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123function, however, quantitative analysis is not possi-
ble in almost half of the patients, due to dark band,
ﬂow and stent artifacts. Image quality of LGE studies
were signiﬁcantly better at 1.5 T. Therefore further
optimization of pulse sequences at 3.0 T is essential.
MR imaging is considered to be contraindicated in
patients with ferromagnetic implants, primarily
because of the potential risks associated with migra-
tion, the induction of an electrical current and heating
of the implant [14, 15]. According to earlier reports
and the American Society for Testing and Materials
International, the overall magnetic ﬁeld interaction
and heating for coronary stents is limited or absent at
1.5 T and 3.0 T, as tested in vitro [16–18]. In vivo
studies concerning stent safety at 1.5 T demonstrated
that CMR scanning is safe in patients early after
coronary artery stent placement [19–21]. In this
in vivo study using both 1.5 T and 3.0 T, no clinical
signs were observed by the attending physician, and
no substantial side effects or clinical events occurred
during or within 30 days of CMR scanning. In
addition, in the patients who underwent a repeat
catheterization there was no angiographic evidence of
stent migration, conﬁrming the in vitro data.
As discussed by Scha ¨r et al. [7], dark band and
ﬂow artifacts in SSFP cine imaging can be solved
using optimized sequence parameters, localized
shimming and correct water resonance frequency
adjustment. In the clinical setting of the present
study, it was not always possible to solve these
Fig. 2 Four chamber cine
SSFP images at 3.0 T in
end-diastole (A & C) and
end-systole (B & D), at the
same slice position in one
patient. Upper panels are
without and lower panels
with localized shimming.
Dark band artifacts (apex)
and ﬂow artifacts (around
the atrioventricular valves)
are reduced with localized
shimming
Table 3 Consensus score of image quality of cine and late gadolinium-enhanced images for 1.5 T and 3.0 T
Cine SSFP images Late gadolinium-enhanced images
1.5 T 3.0 T 1.5 T 3.0 T
1. Not clinically useful 0 (0%) 0 (0%) 0 (0%) 2 (12%)
2. Clinically useful, no quantitative analysis 0 (0%) 8 (44%) 0 (0%) 7 (41%)
3. Clinically useful, quantitatively analyzable 0 (0%) 4 (22%) 1 (6%) 8 (47%)
4. Excellent quality 18 (100%) 6 (33%) 17 (94%) 0 (0%)
Values are presented as absolute numbers (percentage)
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123artifact problems despite sequence optimization and
localized shimming, especially in the presence of
stent artifacts. The larger and diagnostically interfer-
ing artifacts of coronary stents at 3.0 T as opposed to
the smaller stent artifacts at 1.5 T are an important
issue in patients after MI, since primary PCI with
stent implantation is the method of choice to re-
establish coronary ﬂow [22]. For clinical application,
it may be more advantageous to return to spoiled
gradient-echo cine imaging at 3.0 T, which includes
longer acquisition times and lower contrast between
blood and myocardium, but is less sensitive for off-
resonance artifacts and equally accurate as SSFP cine
imaging (Fig. 3)[ 9, 23].
We initially intended to evaluate differences in
signal- and contrast-to-noise ratios (SNR and CNR) of
both pulse sequences as well. At 1.5 T good noise
estimates could be made using the technique
described by Constantinides et al. [24]. However, this
method did not work at 3.0 T due to a different
reconstruction algorithm, even without parallel imag-
ing, and by switching off clear and image
enhancement ﬁlters. Subtraction methods with two
consecutive scans to estimate noise are inaccurate in a
mobile tissue as the heart [25]. Other methods were
beyond the scope of this initial study. Despite the fact
that SNR’s and CNR’s were therefore omitted from
this study, it is interesting to mention that an important
reason for inferior quality of LGE images at 3.0 T was
that infarcted myocardium was sometimes difﬁcult to
delineate from the left ventricular cavity (Fig. 4).
We used the same contrast agent and dose at both
ﬁeld strengths. The contrast dose has been optimized
for 1.5 T in the past [26, 27], but might be different at
3.0 T as T1 relaxation rates are in general ﬁeld
strength dependent. However, a recent study of
Sharma and colleagues showed that there were only
minor differences in post contrast myocardial T1
relaxation times between 1.5 T and 3.0 T, using a
contrast dose of 0.2 mmol/kg [28]. As long as
inversion times are set appropriately at each ﬁeld
strength as done in this study, it is not to be expected
that signiﬁcant differences in LGE image quality are
caused by contrast dose effects.
In conclusion, our study demonstrates that it is safe
and feasible to perform CMR scanning at 3.0 T in the
Fig. 3 Short axis cine
SSFP image (A) and cine
spoiled gradient-echo image
(B), at the same slice
position in one patient at
3.0 T. The coronary stent
artifact on a SSFP image is
larger than on a spoiled
gradient-echo image (white
arrows heads). Flow
artifacts (A, asterisk) are
less visible with spoiled
gradient-echo imaging at
3.0 T
Fig. 4 Short axis LGE
images 15 min after
injection of contrast at
3.0 T (A) and 1.5 T (B), in
different patients. Visual
assessment of infarct extent
and location was more
difﬁcult at 3.0 T than at
1.5 T, since it was
sometimes difﬁcult to
delineate infarcted
myocardium from the left
ventricular cavity at 3.0 T
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123acuteandchronicphaseafterMIinpatientstreatedwith
primary stenting. Although cine imaging at 3.0 T is of
sufﬁcient quality for clinical use, quantitative assess-
ment is less reliable compared to 1.5 T, mainly due to
darkband,ﬂowandstentartifacts.Furtheroptimization
of pulse sequences at 3.0 T is essential to make 3.0 T
CMR scanning suitable for clinical cardiology.
Limitations
The use of different MR systems, from different
vendors, with different coils and sequence parame-
ters, of course introduces confounding factors for a
comparison. However, the sequences were optimized
for their ﬁeld strength to evaluate safety, feasibility
and image quality rather than technical differences. A
second limitation is that patients did not undergo a
CMR examination at both 1.5 T and 3.0 T. Because
the MR systems were on two different locations, it
was not feasible to study the same patient twice in the
acute phase after MI.
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